New Products
Neogen has expanded its commercial genomic profile to include 18 traits, offering cow-calf producers new proactive tools to manage bovine respiratory disease risk and quantify sustainability in dollars.
From enhanced digestive enzymes in Bimeda’s BOVitalize Plus to a 200-day drylot label for Zoetis’ Synovex One Grower, this week’s livestock news highlights a surge in production efficiency tools. Ritchie Industries names Chad Huyser as CEO, while Nofence joins forces with Trust in Food to bring virtual fencing data to more U.S. producers.
From a new animal feed and nutrition company to new animal health products and technology tools, check out these products released an promoted on the trade show floor in Nashville.
As misinformation regarding the use of mRNA vaccines in livestock filter through social media, there are facts begging to be set straight.
The FDA has given its stamp of approval to Elanco’s Bovaer®, a first-in-class methane-reducing feed ingredient.
The CleanVax intranasal vaccination system includes shorter nozzles that are less invasive than conventional cannulas, as well as clear plastic disposable shields that can be replaced between animals.
Bimeda, Inc. announces BOVitalize™ an oral vitamin and mineral supplement for beef and dairy cows, bulls and ruminating calves.
The first dual-active endectocide for the U.S. has been approved for use, starting August 1, in beef cattle 2 months of age and older and in replacement dairy heifers less than 20 months of age.
SpectoGard (spectinomycin sulfate) sterile solution—which received FDA approval in September of 2022—is now available for veterinarians and cattle producers in the United States.
Merck Animal Health is introducing AROVYN – a broad-spectrum antibiotic that treats the major organisms associated with bovine respiratory disease, foot rot and pinkeye.
Texas Agriculture Commissioner Sid Miller announced a new tool in the war against feral hogs with the release of a new hog contraceptive bait entering the market this week.
The product offers proven performance against Mannheimia haemolytica, while adding protection against common viral causes of BRD, including BVD Types 1 and 2 and IBR.
The technology, marketed as FerAppease in the U.S., can be used in beef and dairy animals. Economic analysis, depending on the production stage of use, offers an ROI of 20:1 to 30:1.